194 related articles for article (PubMed ID: 38287357)
1. Magnetic resonance imaging with upconversion nanoprobes capable of crossing the blood-cerebrospinal fluid barrier.
Han F; Gao J; Lv G; Liu T; Hu Q; Zhu M; Du Z; Yang J; Yao Z; Fang X; Ni D; Zhang J
J Nanobiotechnology; 2024 Jan; 22(1):43. PubMed ID: 38287357
[TBL] [Abstract][Full Text] [Related]
2. The cerebrospinal fluid and barriers - anatomic and physiologic considerations.
Tumani H; Huss A; Bachhuber F
Handb Clin Neurol; 2017; 146():21-32. PubMed ID: 29110772
[TBL] [Abstract][Full Text] [Related]
3. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
Engelhardt B; Sorokin L
Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
[TBL] [Abstract][Full Text] [Related]
4. Human CD4
Nishihara H; Soldati S; Mossu A; Rosito M; Rudolph H; Muller WA; Latorre D; Sallusto F; Sospedra M; Martin R; Ishikawa H; Tenenbaum T; Schroten H; Gosselet F; Engelhardt B
Fluids Barriers CNS; 2020 Feb; 17(1):3. PubMed ID: 32008573
[TBL] [Abstract][Full Text] [Related]
5. Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.
Strazielle N; Ghersi-Egea JF
Curr Pharm Des; 2016; 22(35):5463-5476. PubMed ID: 27464721
[TBL] [Abstract][Full Text] [Related]
6. [Kinetic analysis of the disposition of hydrophilic drugs in the central nervous system (CNS): prediction of the CNS disposition from the transport properties in the blood-brain and blood-cerebrospinal fluid barriers].
Suzuki H; Sugiyama Y
Yakugaku Zasshi; 1994 Dec; 114(12):950-71. PubMed ID: 7869236
[TBL] [Abstract][Full Text] [Related]
7. The impact of hypoxia on blood-brain, blood-CSF, and CSF-brain barriers.
Dunn JF; Isaacs AM
J Appl Physiol (1985); 2021 Sep; 131(3):977-985. PubMed ID: 34264124
[TBL] [Abstract][Full Text] [Related]
8. The barrier and interface mechanisms of the brain barrier, and brain drug delivery.
Zhang S; Gan L; Cao F; Wang H; Gong P; Ma C; Ren L; Lin Y; Lin X
Brain Res Bull; 2022 Nov; 190():69-83. PubMed ID: 36162603
[TBL] [Abstract][Full Text] [Related]
9. Aspect Ratio of PEGylated Upconversion Nanocrystals Affects the Cellular Uptake In Vitro and In Vivo.
Fu L; Shi B; Wen S; Morsch M; Wang G; Zhou Z; Mi C; Sadraeian M; Lin G; Lu Y; Jin D; Chung R
Acta Biomater; 2022 Jul; 147():403-413. PubMed ID: 35605956
[TBL] [Abstract][Full Text] [Related]
10. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
11. Application of contrast-enhanced magnetic resonance imaging in the assessment of blood-cerebrospinal fluid barrier integrity.
Verheggen ICM; Freeze WM; de Jong JJA; Jansen JFA; Postma AA; van Boxtel MPJ; Verhey FRJ; Backes WH
Neurosci Biobehav Rev; 2021 Aug; 127():171-183. PubMed ID: 33930471
[TBL] [Abstract][Full Text] [Related]
12. The blood-CSF-brain route of neurological disease: The indirect pathway into the brain.
Cousins O; Hodges A; Schubert J; Veronese M; Turkheimer F; Miyan J; Engelhardt B; Roncaroli F
Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12789. PubMed ID: 34935179
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier.
Zlokovic BV; Jovanovic S; Miao W; Samara S; Verma S; Farrell CL
Endocrinology; 2000 Apr; 141(4):1434-41. PubMed ID: 10746647
[TBL] [Abstract][Full Text] [Related]
14. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons.
Kleine TO; Benes L
Cytometry A; 2006 Mar; 69(3):147-51. PubMed ID: 16479603
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid, Brain Electrolytes Balance, and the Unsuspected Intrinsic Property of Melanin to Dissociate the Water Molecule.
Herrera AS; Ashraf GM; Del Carmen Arias Esparza M; Tarasov VV; Chubarev VN; Avila-Rodriguez MF; Makhmutovа A; Ganash M; Mosa OF; Hafeez A; Bachurin SO; Aliev G
CNS Neurol Disord Drug Targets; 2018; 17(10):743-756. PubMed ID: 30179148
[TBL] [Abstract][Full Text] [Related]
16. Topotecan central nervous system penetration is altered by a tyrosine kinase inhibitor.
Zhuang Y; Fraga CH; Hubbard KE; Hagedorn N; Panetta JC; Waters CM; Stewart CF
Cancer Res; 2006 Dec; 66(23):11305-13. PubMed ID: 17145877
[TBL] [Abstract][Full Text] [Related]
17. Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively.
Johanson C; Johanson N
CNS Neurol Disord Drug Targets; 2016; 15(9):1151-1180. PubMed ID: 27633784
[TBL] [Abstract][Full Text] [Related]
18. Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma.
Ni D; Zhang J; Bu W; Xing H; Han F; Xiao Q; Yao Z; Chen F; He Q; Liu J; Zhang S; Fan W; Zhou L; Peng W; Shi J
ACS Nano; 2014 Feb; 8(2):1231-42. PubMed ID: 24397730
[TBL] [Abstract][Full Text] [Related]
19. Macromolecular drug transport into the brain using targeted therapy.
Lichota J; Skjørringe T; Thomsen LB; Moos T
J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
[TBL] [Abstract][Full Text] [Related]
20. Metabolite transport across central nervous system barriers.
Carstens G; Verbeek MM; Rohlwink UK; Figaji AA; Te Brake L; van Laarhoven A
J Cereb Blood Flow Metab; 2024 Jul; 44(7):1063-1077. PubMed ID: 38546534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
